Calico and Broad Institute Extend Collaboration Adding Focus on Age-Related Neurodegeneration
SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., May 9, 2024 /PRNewswire/ -- Calico Life Sciences LLC (Calico) and the Broad Institute of MIT and Harvard, announced today that the two organizations have further extended their partnership with an added focus on age-related neurodegeneration.
- SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., May 9, 2024 /PRNewswire/ -- Calico Life Sciences LLC (Calico) and the Broad Institute of MIT and Harvard, announced today that the two organizations have further extended their partnership with an added focus on age-related neurodegeneration.
- "We are pleased to continue our collaboration with the Broad Institute.
- "Renewing our commitment to this partnership with Calico reflects our shared goal of advancing transformative biomedical research and therapies for age-related diseases," said Todd Golub, M.D., Director and founding core member of the Broad Institute.
- We look forward to working with the Calico team to further our insights into how aging impacts the brain and neurological function."